Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi018-A) from a patient with Charcot-Marie-Tooth disease type 2EE (CMT2EE) due to a homozygous c.122G > A p.(Arg41Gln) mutation in the MPV17 gene.
A Ababneh N, Barham R, Al-Kurdi B, Al Hadidi S, Ali D, Abdulelah AA, Madadha A, Masri A, Awidi A. A Ababneh N, et al. Among authors: al hadidi s. Stem Cell Res. 2024 Dec;81:103602. doi: 10.1016/j.scr.2024.103602. Epub 2024 Oct 22. Stem Cell Res. 2024. PMID: 39461114 Free article.
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma.
Patel TH, Bachu R, Shrivastava T, Alrawabdeh J, Alzubi M, Hastings J, Dean H, Schinke C, Thanendrarajan S, Zangari M, Tricot G, Zhan F, Shaughnessy JD, van Rhee F, Al Hadidi S. Patel TH, et al. Among authors: al hadidi s. Clin Hematol Int. 2024 Sep 24;6(3):54-60. doi: 10.46989/001c.123608. eCollection 2024. Clin Hematol Int. 2024. PMID: 39345654 Free PMC article.
Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.
Kakkilaya A, Trando A, Cliff ERS, Mian H, Al Hadidi S, Aziz M, Goodman AM, Jeong AR, Smith WL, Kelkar AH, Russler-Germain DA, Mehra N, Chakraborty R, Gertz MA, Mohyuddin GR. Kakkilaya A, et al. Among authors: al hadidi s. Oncologist. 2024 Sep 5:oyae219. doi: 10.1093/oncolo/oyae219. Online ahead of print. Oncologist. 2024. PMID: 39236068 Free article.
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.
Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M. Akhtar OS, et al. Among authors: al hadidi s. Br J Haematol. 2024 Nov;205(5):1830-1834. doi: 10.1111/bjh.19700. Epub 2024 Aug 27. Br J Haematol. 2024. PMID: 39192546
125 results